Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Cancer Causes & Control
Erschienen in: Cancer Causes & Control 1/2012

01.01.2012 | Review article

Vitamin D and mammographic breast density: a systematic review

verfasst von: Lusine Yaghjyan, Graham A. Colditz, Bettina Drake

Erschienen in: Cancer Causes & Control | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Studies suggest a protective relationship between Vitamin D and breast cancer risk. Several studies assessed the association of Vitamin D with mammographic breast density, a known and strong breast cancer risk factor. Understanding the potential role of Vitamin D in the modification of breast density might open new avenues in breast cancer prevention. This systematic review summarizes published studies that investigated the association between Vitamin D and mammographic breast density and offers suggestions for strategies to advance our scientific knowledge.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798–808PubMedCrossRef
2.
Ginsburg OM, Martin LJ, Boyd NF (2008) Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 99(9):1369–1374PubMedCrossRef
3.
Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178–1187PubMedCrossRef
4.
Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230(1):29–41PubMedCrossRef
5.
Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670–675PubMedCrossRef
6.
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622–1629PubMedCrossRef
7.
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236PubMedCrossRef
8.
Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14(2):343–349PubMedCrossRef
9.
Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171–176PubMedCrossRef
10.
Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA (2007) Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(5):921–928PubMedCrossRef
11.
Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC (1994) Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86(6):431–436PubMedCrossRef
12.
Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121(2):469–477PubMedCrossRef
13.
Khan QJ, Kimler BF, Fabian CJ (2010) The relationship between vitamin D and breast cancer incidence and natural history. Curr Oncol Rep 12(2):136–142PubMedCrossRef
14.
Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R (2007) Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(3):422–429PubMedCrossRef
15.
Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 94(17):1301–1311PubMed
16.
Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12):2196–2205PubMedCrossRef
17.
IARC (2008) Vitamin D and cancer. France
18.
Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2):83–95PubMedCrossRef
19.
Cui Y, Rohan TE (2006) Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15(8):1427–1437PubMedCrossRef
20.
Chouvet C, Vicard E, Devonec M, Saez S (1986) 1, 25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24(1):373–376PubMedCrossRef
21.
Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J (1996) 1, 25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 58(4):367–376PubMedCrossRef
22.
Narvaez CJ, Zinser G, Welsh J (2001) Functions of 1alpha, 25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids 66(3–5):301–308PubMedCrossRef
23.
Xue L, Lipkin M, Newmark H, Wang J (1999) Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst 91(2):176–181PubMedCrossRef
24.
Colston KW, Hansen CM (2002) Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9(1):45–59PubMedCrossRef
25.
Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs–a brief overview. Mol Cell Biochem 253(1–2):247–254PubMedCrossRef
26.
Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9):684–700PubMedCrossRef
27.
Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 80(6 Suppl):1721S–1724SPubMed
28.
Krishnan AV, Swami S, Feldman D (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121(1–2):343–348PubMedCrossRef
29.
Pattarozzi A, Gatti M, Barbieri F, Wurth R, Porcile C, Lunardi G, Ratto A, Favoni R, Bajetto A, Ferrari A, Florio T (2008) 17-beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 73(1):191–202PubMedCrossRef
30.
LaMarca HL, Rosen JM (2007) Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res 9(4):304PubMedCrossRef
31.
Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006) 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20(10):1622–1634PubMedCrossRef
32.
Seeger H, Deuringer FU, Wallwiener D, Mueck AO (2004) Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation. Maturitas 49(3):235–240PubMedCrossRef
33.
Johansson CM, Anderson TJ, Bergstrom R, Lindgren A, IR P (1998) Epithelial proliferation in the normal human breast in relation to endogenous hormones and oral contraceptive use. The Breast 7:162–167CrossRef
34.
Sutherland RL, Prall OW, Watts CK, Musgrove EA (1998) Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia 3(1):63–72PubMedCrossRef
35.
Foidart JM, Colin C, Denoo X, Desreux J, Beliard A, Fournier S, de Lignieres B (1998) Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 69(5):963–969PubMedCrossRef
36.
Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15(1):17–35PubMed
37.
38.
Zhu BTCA (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1–27PubMedCrossRef
39.
Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10:483PubMedCrossRef
40.
Tseng M, Byrne C, Evers KA, Daly MB (2007) Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Res 9(5):R72PubMedCrossRef
41.
Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6(1):5–30PubMedCrossRef
42.
Diorio C, Berube S, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, Cote G, Pollak M, Brisson J (2006) Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res 66(1):588–597PubMedCrossRef
43.
Tworoger S, Hankinson S (2006) Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17(7):889–899PubMedCrossRef
44.
Jeffreys M, Warren R, Smith GD, Gunnell D (2003) Breast density: agreement of measures from film and digital image. Br J Radiol 76(908):561–563PubMedCrossRef
45.
Lee-Han H, Cooke G, Boyd NF (1995) Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev 4(4):285–292PubMedCrossRef
46.
Muhimmah I, Zwiggelaar R (2006) Mammographic density classification using multiresolution histogram information. In: The international special topic conference on information technology in biomedicine (ITAB’06). Ioannina, Greece
47.
Colangelo LA, Chiu BCH, Lopez P, Scholtens D, Willis LC, Hendrick RE, Gapstur SM (2006) A pilot study of vitamin D, calcium, and percent breast density in Hispanic women. Nutrition Research 26(1):11–15CrossRef
48.
Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14(2):243–250PubMedCrossRef
49.
Berube S, Diorio C, Masse B, Hebert-Croteau N, Byrne C, Cote G, Pollak M, Yaffe M, Brisson J (2005) Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14(7):1653–1659PubMedCrossRef
50.
Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B (2007) Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev 16(5):929–933PubMedCrossRef
51.
Bertone-Johnson ER, Chlebowski RT, Manson JE, Wactawski-Wende J, Aragaki AK, Tamimi RM, Rexrode KM, Thomson CA, Rohan TE, Peck JD, Pisano ED, Martin CF, Sarto G, McTiernan A (2010) Dietary vitamin D and calcium intake and mammographic density in postmenopausal women. Menopause 17(6):1152–1160PubMedCrossRef
52.
Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA (2006) No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev 15(10):1988–1992PubMedCrossRef
53.
Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9(2):151–160PubMed
54.
Green AK, Hankinson SE, Bertone-Johnson ER, Tamimi RM (2010) Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer 127(3):667–674PubMedCrossRef
55.
Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006) Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118(7):1782–1789PubMedCrossRef
56.
Mishra G, McCormack V, Kuh D, Hardy R, Stephen A, dos Santos Silva I (2008) Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer 99(9):1539–1543PubMedCrossRef
57.
Neuhouser ML, Bernstein L, Hollis BW, Xiao L, Ambs A, Baumgartner K, Baumgartner R, McTiernan A, Ballard-Barbash R (2010) Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 19(2):412–417PubMedCrossRef
58.
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan T, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA (2011) 25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas 68(1):73–78PubMedCrossRef
59.
Wu H, Gozdzik A, Barta JL, Wagner D, Cole DE, Vieth R, Parra EJ, Whiting SJ (2009) The development and evaluation of a food frequency questionnaire used in assessing vitamin D intake in a sample of healthy young Canadian adults of diverse ancestry. Nutr Res 29(4):255–261PubMedCrossRef
60.
Signorello LB, Williams SM, Zheng W, Smith JR, Long J, Cai Q, Hargreaves MK, Hollis BW, Blot WJ (2010) Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry. Cancer Epidemiol Biomarkers Prev 19(9):2325–2331PubMedCrossRef
61.
Sinotte M, Diorio C, Berube S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89(2):634–640PubMedCrossRef
62.
D’Alésio A, Garabédian M, Sabatier JP, Guaydier-Souquières G, Marcelli C, Lemaçon A, Walrant-Debray O, Jehan F (2005) Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein–DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet 14(22):3539–3548PubMedCrossRef
63.
Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly P (1995) Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 80(9):2800–2805PubMedCrossRef
64.
Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19(4):927–931PubMedCrossRef
65.
Higashi T, Shimada K, Toyo’oka T (2010) Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. J Chromatogr B Analyt Technol Biomed Life Sci 878(20):1654–1661PubMedCrossRef
66.
Chai W, Maskarinec G, Cooney RV (2010) Serum 25-hydroxyvitamin D levels and mammographic density among premenopausal women in a multiethnic population. Eur J Clin Nutr 64(6):652–654PubMedCrossRef
67.
Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28(24):3830–3837PubMedCrossRef
68.
Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM (2010) Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28(13):2207–2212PubMedCrossRef
69.
Munir J, Birge S (2008) Vitamin D Deficiency in Pre and Postmenopausal Women. Menopause Management 17(5):10–21
70.
Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R (2002) Estrogens (E2) regulate expression and response of 1, 25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 299(3):446–454PubMedCrossRef
71.
Talley LI, Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR (2002) Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 98(1):118–127PubMedCrossRef
72.
Misell L, Hwang E, Au A, Esserman L, Hellerstein M (2005) Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat 89(3):257–264PubMedCrossRef
73.
Guillemette C, Belanger A, Lepine J (2004) Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6(6):246–254PubMedCrossRef
74.
Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285PubMedCrossRef
75.
Ursin G, Parisky YR, Pike MC, Spicer DV (2001) Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10(2):141–142PubMed
76.
White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, Yasui Y, Taplin SH (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 Years. J Natl Cancer Inst 90(12):906–910PubMedCrossRef
77.
Berube S, Diorio C, Brisson J (2008) Multivitamin-multimineral supplement use and mammographic breast density. Am J Clin Nutr 87(5):1400–1404PubMed
Metadaten
Titel
Vitamin D and mammographic breast density: a systematic review
verfasst von
Lusine Yaghjyan
Graham A. Colditz
Bettina Drake
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9851-3

Weitere Artikel der Ausgabe 1/2012

Cancer Causes & Control 1/2012 Zur Ausgabe

Original paper

Factors associated with mortality after breast cancer metastasis

Original Paper

Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women

Original paper

Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica

Original paper

Sun protective behaviors and vitamin D levels in the US population: NHANES 2003–2006

Original Paper

Improved survival among patients with base of tongue and tonsil cancer in the United States

Original paper

Hormone therapy and ovarian borderline tumors: a national cohort study

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise